Considering Clinical Trials: An MPN Expert Explains Why Treatment Options Matter With Myelofibrosis
Topic Areas:
Myeloproliferative Neoplasms
Published on August 2, 2017
Dr. Catriona Jamieson, from Moores Cancer Center at UC San Diego Health, joined Patient Power to discuss considerations when choosing to participate in a clinical trial. Dr. Jamieson sheds light on the necessity of ongoing MPN clinical trials, particularly for myelofibrosis, as well as how to talk to your doctor about this treatment option.
